Back

AstraZeneca's Trixeo Aerosphere wins EU approval for asthma treatment

Verifying
  • AstraZeneca PLC received EU approval for its asthma treatment Trixeo Aerosphere.
  • Mid-single-digit revenue growth is supporting stronger earnings-per-share gains.
  • The approval expands AstraZeneca's market in Respiratory & Immunology.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.